Ampio Pharmaceuticals Inc.

1.56-0.0100-0.64%Vol 1.63M1Y Perf 191.78%
Apr 19th, 2021 15:29 DELAYED
BID1.55 ASK1.56
Open1.52 Previous Close1.57
Pre-Market- After-Market-
 - -%  - -
Target Price
4.00 
Analyst Rating
Strong Buy 1.00
Potential %
154.96 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap305.18M 
Earnings Rating
Buy
Price Range Ratio 52W %
43.80 
Earnings Date
5th May 2021

Today's Price Range

1.441.58

52W Range

0.45352.98

5 Year PE Ratio Range

-2.301.70

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-13.74%
1 Month
-13.74%
3 Months
15.44%
6 Months
91.46%
1 Year
191.78%
3 Years
-48.36%
5 Years
-54.09%
10 Years
-45.86%

TickerPriceChg.Chg.%
AMPE1.56-0.0100-0.64
AAPL134.270.11000.08
GOOG2 297.56-0.2000-0.01
MSFT258.29-2.4500-0.94
XOM56.20-0.4600-0.81
WFC43.900.06000.14
JNJ162.580.34000.21
FB300.93-5.2500-1.71
GE13.410.02000.15
JPM152.77-0.5300-0.35
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.02-0.020.00
Q03 2020-0.02-0.020.00
Q02 2020-0.04-0.0250.00
Q01 2020-0.04-0.040.00
Q03 2019--0.05-
Q02 2019--0.03-
Q01 2019--0.05-
Q02 2018-0.05-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.0275.00Positive
6/2021 QR-0.02--
12/2021 FY-0.09--
12/2022 FY-0.08--
Next Report Date5th May 2021
Estimated EPS Next Report-0.02
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume1.63M
Shares Outstanding195.63M
Trades Count5.09K
Dollar Volume4.07M
Avg. Volume3.40M
Avg. Weekly Volume1.39M
Avg. Monthly Volume1.31M
Avg. Quarterly Volume3.26M

Ampio Pharmaceuticals Inc. (AMEX: AMPE) stock closed at 1.57 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 1.34M shares and market capitalization of 305.18M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 23 people. Ampio Pharmaceuticals Inc. CEO is Michael E. Macaluso.

The one-year performance of Ampio Pharmaceuticals Inc. stock is 191.78%, while year-to-date (YTD) performance is -1.26%. AMPE stock has a five-year performance of -54.09%. Its 52-week range is between 0.4535 and 2.98, which gives AMPE stock a 52-week price range ratio of 43.80%

Ampio Pharmaceuticals Inc. currently has a PE ratio of -18.40, a price-to-book (PB) ratio of 20.55, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -83.39%, a ROC of -141.04% and a ROE of -129.61%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Ampio Pharmaceuticals Inc., there were 1 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.02 for the next earnings report. Ampio Pharmaceuticals Inc.’s next earnings report date is 05th May 2021.

The consensus rating of Wall Street analysts for Ampio Pharmaceuticals Inc. is Strong Buy (1), with a target price of $4, which is +154.96% compared to the current price. The earnings rating for Ampio Pharmaceuticals Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Ampio Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Ampio Pharmaceuticals Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 24.08, ATR14 : 0.19, CCI20 : -133.98, Chaikin Money Flow : -0.11, MACD : -0.06, Money Flow Index : 31.90, ROC : -4.27, RSI : 38.73, STOCH (14,3) : 23.26, STOCH RSI : 0.00, UO : 47.52, Williams %R : -76.74), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Ampio Pharmaceuticals Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Ampio Pharmaceuticals Inc.

Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company focused primarily on developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process and decreasing vascular permeability. Ampio's leading product candidates are Ampion and Optina. It is currently conducting the second pivotal clinical trial in the United States for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.

CEO: Michael E. Macaluso

Telephone: +1 720 437-6500

Address: 373 Inverness Parkway, Englewood 80112, CO, US

Number of employees: 23

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

73%27%

Bearish Bullish

59%41%

Bearish Bullish

66%34%

News

Stocktwits